Literature DB >> 25442403

Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).

Abraham Palache1, Valerie Oriol-Mathieu2, Atika Abelin3, Tamara Music4.   

Abstract

Globally there are an estimated 3-5 million cases of severe influenza illness every year, resulting in 250,000-500,000 deaths. At the World Health Assembly in 2003, World Health Organization (WHO) resolved to increase influenza vaccine coverage rates (VCR) for high-risk groups, particularly focusing on at least 75% of the elderly by 2010. But systematic worldwide data have not been available to assist public health authorities to monitor vaccine uptake and review progress toward vaccination coverage targets. In 2008, the International Federation of Pharmaceutical Manufacturers and Associations Influenza Vaccine Supply task force (IFPMA IVS) developed a survey methodology to assess global influenza vaccine dose distribution. The current survey results represent 2011 data and demonstrate the evolution of the absolute number distributed between 2004 and 2011 inclusive, and the evolution in the per capita doses distributed in 2008-2011. Global distribution of IFPMA IVS member doses increased approximately 86.9% between 2004 and 2011, but only approximately 12.1% between 2008 and 2011. The WHO's regions in Eastern Mediterranean (EMRO), Southeast Asian (SEARO) and Africa (AFRO) together account for about 47% of the global population, but only 3.7% of all IFPMA IVS doses distributed. While distributed doses have globally increased, they have decreased in EURO and EMRO since 2009. Dose distribution can provide a reasonable proxy of vaccine utilization. Based on the dose distribution, we conclude that seasonal influenza VCR in many countries remains well below the WHA's VCR targets and below the recommendations of the Council of the European Union in EURO. Inter- and intra-regional disparities in dose distribution trends call into question the impact of current vaccine recommendations at achieving coverage targets. Additional policy measures, particularly those that influence patients adherence to vaccination programs, such as reimbursement, healthcare provider knowledge, attitudes, practices, and communications, are required for VCR targets to be met and benefit public health.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Monitoring and evaluation; Seasonal influenza; Vaccination coverage rates; Vaccination policy; Vaccine recommendations; Vaccine reimbursement

Mesh:

Substances:

Year:  2014        PMID: 25442403     DOI: 10.1016/j.vaccine.2014.07.012

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  Emergency Department influenza vaccination campaign allows increasing influenza vaccination coverage without disrupting time interval quality indicators.

Authors:  Enrique Casalino; Aiham Ghazali; Donia Bouzid; Stephanie Antoniol; Philippe Kenway; Laurent Pereira; Christophe Choquet
Journal:  Intern Emerg Med       Date:  2018-05-25       Impact factor: 3.397

2.  Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.

Authors:  Chunna Ma; Yang Pan; Li Zhang; Yi Zhang; Shuangsheng Wu; Ying Sun; Wei Duan; Man Zhang; Quanyi Wang; Peng Yang
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 3.  Universal influenza virus vaccines and therapeutic antibodies.

Authors:  R Nachbagauer; F Krammer
Journal:  Clin Microbiol Infect       Date:  2017-02-12       Impact factor: 8.067

4.  Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent.

Authors:  Yoo Chun Kim; Jeong Woo Lee; E Stein Esser; Haripriya Kalluri; Jessica C Joyce; Richard W Compans; Ioanna Skountzou; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2021-02-15       Impact factor: 4.617

5.  The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine.

Authors:  Jack A Panapasa; Rebecca J Cox; Kristin G I Mohn; Lara A Aqrawi; Karl A Brokstad
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016.

Authors:  Laura P Newman; Niranjan Bhat; Jessica A Fleming; Kathleen M Neuzil
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

7.  Patient's behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient's influenza vaccine uptake.

Authors:  Enrique Casalino; Aiham Ghazali; Donia Bouzid; Stephanie Antoniol; Laurent Pereira; Philippe Kenway; Christophe Choquet
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

8.  Antiviral Activities of Several Oral Traditional Chinese Medicines against Influenza Viruses.

Authors:  Lin-Lin Ma; Miao Ge; Hui-Qiang Wang; Jin-Qiu Yin; Jian-Dong Jiang; Yu-Huan Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-08       Impact factor: 2.629

Review 9.  Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review.

Authors:  Siddhivinayak Hirve; Philipp Lambach; John Paget; Katelijn Vandemaele; Julia Fitzner; Wenqing Zhang
Journal:  Influenza Other Respir Viruses       Date:  2016-05-26       Impact factor: 4.380

10.  Seasonal influenza vaccination policies in the 194 WHO Member States: The evolution of global influenza pandemic preparedness and the challenge of sustaining equitable vaccine access.

Authors:  Kathleen F Morales; David W Brown; Laure Dumolard; Claudia Steulet; Alba Vilajeliu; Alba Maria Ropero Alvarez; Ann Moen; Martin Friede; Philipp Lambach
Journal:  Vaccine X       Date:  2021-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.